BAYRY - Bayer Aktiengesellschaft

Other OTC - Other OTC Delayed Price. Currency in USD
16.90
-0.47 (-2.68%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close17.36
Open16.95
Bid0.00 x 0
Ask0.00 x 0
Day's Range16.75 - 16.95
52 Week Range15.67 - 32.80
Volume710,466
Avg. Volume998,859
Market Cap63.407B
Beta (3Y Monthly)0.85
PE Ratio (TTM)9.16
EPS (TTM)1.84
Earnings DateN/A
Forward Dividend & Yield0.81 (5.05%)
Ex-Dividend Date2019-04-29
1y Target Est21.50
Trade prices are not sourced from all markets
  • Bayer Gets Boost From Agriculture as Investor Meeting Looms
    Bloomberg1 hour ago

    Bayer Gets Boost From Agriculture as Investor Meeting Looms

    Bayer rose as much as 4.5 percent in Frankfurt, its biggest gain since early January. Monsanto’s growth rate is welcome news for Baumann, coming despite flooding in the U.S. Midwest that hurt rivals including DowDuPont Inc. and the impact of China trade tensions on the U.S. soybean sector.

  • Financial Times3 hours ago

    Bayer outlines widening lawsuits over weedkiller cancer allegations

    Bayer reported a sharp rise in earnings as its results were boosted by its acquisition of US seed business Monsanto, but the German pharmaceutical and chemical group also outlined the widening legal fallout from its blockbuster deal last year. Bayer on Thursday said sales in the first quarter rose 4.1 per cent to €13.01 billion, while core earning before interest, tax, depreciation and amortisation rose 44.6 per cent to €4.188 billion. The $63bn acquisition of Monsanto last year has turned the German group into the leading player in the global market for seeds and crop protection products.

  • Bayer gets Monsanto profit boost but legal burden mounts
    Reuters3 hours ago

    Bayer gets Monsanto profit boost but legal burden mounts

    German drug and farming supplies company Bayer posted a 45 percent gain in quarterly core earnings thanks to the acquisition of seed maker Monsanto, while the legal burden it took on with the deal mounted. Bayer said 13,400 plaintiffs were seeking damages, alleging that use of the company's glyphosate-based weedkillers caused their cancer, up from 11,200 in January. Bayer has seen about 30 billion euros ($34 billion) wiped off its market value since August, when a California jury in that lawsuit found that Monsanto should have warned of the alleged cancer risks.

  • Bayer asks California appeals court to throw out $78 million Roundup verdict
    Reuters16 hours ago

    Bayer asks California appeals court to throw out $78 million Roundup verdict

    In a filing in California's Court of Appeal, First Appellate District, the company said that there was "no evidence" that glyphosate, a chemical found in the company's Roundup and Ranger Pro products, could cause cancer. "Bayer stands behind these products and will continue to vigorously defend them," the company said in a news release. The widely-used weed killers are made by Monsanto, which Bayer acquired last year for $63 billion.

  • Bayer (BAYRY) Upgraded to Strong Buy: What Does It Mean for the Stock?
    Zacks21 hours ago

    Bayer (BAYRY) Upgraded to Strong Buy: What Does It Mean for the Stock?

    Bayer (BAYRY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • Bayer's Embattled CEO Faces Growing Shareholder Opposition
    Bloombergyesterday

    Bayer's Embattled CEO Faces Growing Shareholder Opposition

    A growing number of shareholders have said they won’t support executives and supervisory board members in a no-confidence vote at Friday’s annual meeting in Bonn, Germany. Buying Monsanto was supposed to secure Bayer’s position in the rapidly consolidating agrochemicals market and deter outside forces from trying to split up the company, which sells everything from aspirin and cancer medicines to shoe inserts and soybean seeds.

  • Top shareholder won't back Bayer management in AGM vote - sources
    Reuters2 days ago

    Top shareholder won't back Bayer management in AGM vote - sources

    LONDON/FRANKFURT (Reuters) - Bayer's largest shareholder, fund manager BlackRock, will not support the German company's management in a key vote at its annual general meeting (AGM) on Friday, two people familiar with the situation told Reuters. About 30 billion euros ($34 billion) has been wiped off the pesticides and drugs firm's market value since August, when a U.S. jury found Bayer liable because Monsanto, which it bought for $63 billion last year, had not warned of alleged cancer risks linked to its weedkiller Roundup. Bayer suffered a similar courtroom defeat last month and more than 11,000 plaintiffs are claiming damages.

  • Top shareholder won't back Bayer management in AGM vote: sources
    Reuters2 days ago

    Top shareholder won't back Bayer management in AGM vote: sources

    LONDON/FRANKFURT (Reuters) - Bayer's largest shareholder, fund manager BlackRock, will not support the German company's management in a key vote at its annual general meeting (AGM) on Friday, two people familiar with the situation told Reuters. About 30 billion euros ($34 billion) has been wiped off the pesticides and drugs firm's market value since August, when a U.S. jury found Bayer liable because Monsanto, which it bought for $63 billion last year, had not warned of alleged cancer risks linked to its weedkiller Roundup. Bayer suffered a similar courtroom defeat last month and more than 11,000 plaintiffs are claiming damages.

  • What's in Store for Bayer (BAYRY) This Earnings Season?
    Zacks3 days ago

    What's in Store for Bayer (BAYRY) This Earnings Season?

    Bayer (BAYRY) is expected to provide pipeline updates along with its first-quarter results.

  • AVEO Pharmaceuticals Down More Than 40% in 90 Days: Here's Why
    Zacks7 days ago

    AVEO Pharmaceuticals Down More Than 40% in 90 Days: Here's Why

    AVEO Pharmaceuticals (AVEO) suffers a major hindrance as it defers its NDA filing for Fotivda in the United States.

  • Barrons.com7 days ago

    ‘Goodwill’ Write-Offs Are an Earnings Killer. How to Spot Trouble Coming.

    Companies write off “goodwill” when the value of acquired assets declines. It happened at Kraft Heinz and GE. Keep an eye on Bayer and Cigna next.

  • Are Investors Undervaluing Bayer (BAYRY) Right Now?
    Zacks8 days ago

    Are Investors Undervaluing Bayer (BAYRY) Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Ultragenyx's (RARE) UX007 Gets Fast Track Status by FDA
    Zacks8 days ago

    Ultragenyx's (RARE) UX007 Gets Fast Track Status by FDA

    Ultragenyx???s (RARE) UX007 receives Fast Track designation and Rare Pediatric Disease designation by the FDA for the treatment of long-chain fatty acid oxidation disorders.

  • Zacks.com featured expert Kevin Matras highlights: Mallinckrodt Public, Bayer Aktiengesellschaft, United Natural Foods, Tutor Perini and G-III Apparel
    Zacks13 days ago

    Zacks.com featured expert Kevin Matras highlights: Mallinckrodt Public, Bayer Aktiengesellschaft, United Natural Foods, Tutor Perini and G-III Apparel

    Zacks.com featured expert Kevin Matras highlights: Mallinckrodt Public, Bayer Aktiengesellschaft, United Natural Foods, Tutor Perini and G-III Apparel

  • Bayer says to comply with court mediation order in glyphosate case
    Reuters13 days ago

    Bayer says to comply with court mediation order in glyphosate case

    Bayer said on Friday it would comply with a U.S. federal judge's order to enter mediation with a plaintiff who claims the company failed to warn against an alleged cancer risk from its Roundup weedkiller. Bayer has seen billions wiped off its market value since August, when a first U.S. jury found Bayer liable because Monsanto, acquired by Bayer for $63 billion last year, had not warned of the alleged risk from Roundup, which is based on active ingredient glyphosate. U.S. District Judge Vince Chhabria, who presided over the first two cases in federal court, said in a filing dated Thursday that Bayer and another plaintiff, Elaine Stevick, were ordered to start confidential mediation.

  • Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon
    Zacks13 days ago

    Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon

    Novartis' (NVS) Sandoz signs an agreement with Japanese company, Shionogi, to commercialize constipation drug in key European markets.

  • Bayer (BAYRY) Stock Moves -1.33%: What You Should Know
    Zacks14 days ago

    Bayer (BAYRY) Stock Moves -1.33%: What You Should Know

    Bayer (BAYRY) closed at $17.02 in the latest trading session, marking a -1.33% move from the prior day.

  • Reuters14 days ago

    French court finds Bayer's Monsanto liable for farmer's sickness

    PARIS/LYON (Reuters) - A French court has ruled that Monsanto was liable for the sickness of a farmer who inhaled one of its weedkillers, in another legal setback for the Bayer-owned business over health claims. In the latest stage of a decade-long legal tussle, the appeals court in Lyon on Thursday found in favour of farmer Paul Francois' claim that Monsanto's Lasso weedkiller had made him sick and that the product's labelling had been inadequate. "Mr Francois justifiably concludes that the product, due to its inadequate labelling that did not respect applicable regulations, did not offer the level of safety he could legitimately expect," the court said in its ruling.

  • Reuters14 days ago

    U.S. criticizes Vietnam ban of glyphosate herbicide imports

    Vietnam's government said in a statement that the toxic level of herbicides containing glyphosate had long been of concern, in the latest display of global worries over the product's impact on human health. Glyphosate, the chemical contained in Bayer AG's best-selling weed killer Roundup, is the target of thousands of lawsuits in the United States alleging exposure to it causes cancer. Roundup, which Bayer acquired with its $63 billion purchase of Monsanto last year, was the first to contain glyphosate, the world's most widely used weed killer.

  • Reuters14 days ago

    Bayer considers legal options after French court rules for farmer

    German chemical group Bayer said it was considering its legal options, including an appeal, after a French court ruled in favour of a farmer who blamed a weedkiller of Bayer's Monsanto unit for health problems. Thursday's ruling by an appeals court in Lyon in southeast France was the latest stage in a decade-long legal tussle between Monsanto and farmer Paul Francois, who says he fell ill after inhaling weedkiller Lasso in 2004.